Calcineurin inhibitor-free immunosuppression in renal allograft recipients with thrombotic microangiopathy/hemolytic uremic syndrome.
about
Atypical hemolytic uremic syndromeThrombotic microangiopathy after kidney transplantation.Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation.Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.Use of belatacept as alternative immunosuppression in three renal transplant patients with de novo drug-induced thrombotic microangiopathyThe pros and the cons of mTOR inhibitors in kidney transplantation.Dose kidney transplant nephrectomy stop disease progression in plasma exchange resistant post transplant hemolytic uremic syndrome? A case report.Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS.Differing tales of two patients after receiving a kidney transplant from a donor with disseminated intravascular coagulationUpdate on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.An evaluation of sirolimus in renal transplantation.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Managing transplant rejection in the elderly: the benefits of less aggressive immunosuppressive regimens.Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
P2860
Q21202864-BEB22409-C670-4396-86AB-C86B3A8A4F4BQ33372586-2B593BC4-23C8-4A53-8FC9-611146D47298Q33396637-6BC0B5ED-0DC1-44AA-B7D1-98814BF08D34Q33405522-43437FEC-2A3C-4B65-ADDB-DA50DD75257DQ33411321-BBF07E09-5175-48F6-954C-398DA6D75FDBQ33412367-A269582E-F8D6-4EC2-93B1-40BD849600A7Q33413018-D949F495-FB5B-4CCA-B24B-74F11101399EQ33417375-82CAFC1A-B7CD-478D-883B-C1AE7DDD0319Q33423743-C2E45669-3B60-429E-AB4C-16A52EE705DFQ33908301-9D1DABE3-3E91-4F65-95D3-1D5AC93BDB5AQ37322141-39B17AB4-5381-4937-9A04-01352C63A1D3Q38038696-87CCB7C0-078C-42D2-86A2-1A9118F643E3Q42086661-5465E19F-E82E-48F5-B105-8F1F6648E48FQ45078004-8E169E0C-2F32-476C-A0E6-FFE2775F0DE5Q46753398-25680112-652A-42AC-95D8-F259657280BD
P2860
Calcineurin inhibitor-free immunosuppression in renal allograft recipients with thrombotic microangiopathy/hemolytic uremic syndrome.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Calcineurin inhibitor-free imm ...... thy/hemolytic uremic syndrome.
@ast
Calcineurin inhibitor-free imm ...... thy/hemolytic uremic syndrome.
@en
type
label
Calcineurin inhibitor-free imm ...... thy/hemolytic uremic syndrome.
@ast
Calcineurin inhibitor-free imm ...... thy/hemolytic uremic syndrome.
@en
prefLabel
Calcineurin inhibitor-free imm ...... thy/hemolytic uremic syndrome.
@ast
Calcineurin inhibitor-free imm ...... thy/hemolytic uremic syndrome.
@en
P2093
P2860
P1476
Calcineurin inhibitor-free imm ...... athy/hemolytic uremic syndrome
@en
P2093
P2860
P304
P356
10.1111/J.1600-6143.2005.01184.X
P407
P577
2006-02-01T00:00:00Z